Vietnam conditionally approves Cuban Covid-19 vaccine emergency use

The Ministry of Health has just issued a decision on conditionally approving a Cuban Covid-19 vaccine for emergency use in Vietnam.

The Ministry of Health on Friday issued a decision on conditionally approving a Cuban Covid-19 vaccine for emergency use in Vietnam.

The Abdala vaccine produced by Cuba’s AICA Laboratories was packaged at the Centre for Genetic Engineering and Biotechnology (CIGB) in Havana.

The Centre for Research and Production of Vaccines and Biologicals proposed the approval of the vaccine.

The Drug Administration of Vietnam is responsible for licensing the import of the Cuban vaccine. Meanwhile, the Administration of Science Technology and Training will select and guide qualified units to assess the vaccine's safety and efficacy based on advice from the advisory council on the use of vaccines and biologicals.

The National Institute for Control of Vaccine and Biologicals has been assigned to conduct checks and grant certificates for batches of the vaccine before use.

Earlier, the Ministry of Health approved the Hayat-Vax vaccine for emergency use in Covid-19 prevention and control.

At present, there are seven foreign Covid-19 vaccines that have obtained a license for emergency use in Vietnam, namely AstraZeneca by AstraZeneca, Vero Cell by China National Biotec Group (CNBG)/Sinopharm, Sputnik V, Pfizer, Moderna and Johnson & Johnson, and Hayat-Vax.